Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Treatment Period	STARTED	500 U/mL Insulin Efsitora Alfa	343
Treatment Period	STARTED	100 U/mL Insulin Degludec	349
Treatment Period	Received at Least One Dose of Study Drug	500 U/mL Insulin Efsitora Alfa	343
Treatment Period	Received at Least One Dose of Study Drug	100 U/mL Insulin Degludec	349
Treatment Period	COMPLETED	500 U/mL Insulin Efsitora Alfa	316
Treatment Period	COMPLETED	100 U/mL Insulin Degludec	319
Treatment Period	NOT COMPLETED	500 U/mL Insulin Efsitora Alfa	27
Treatment Period	NOT COMPLETED	100 U/mL Insulin Degludec	30
Follow-Up Period	STARTED	500 U/mL Insulin Efsitora Alfa	332
Follow-Up Period	STARTED	100 U/mL Insulin Degludec	326
Follow-Up Period	COMPLETED	500 U/mL Insulin Efsitora Alfa	328
Follow-Up Period	COMPLETED	100 U/mL Insulin Degludec	324
Follow-Up Period	NOT COMPLETED	500 U/mL Insulin Efsitora Alfa	4
Follow-Up Period	NOT COMPLETED	100 U/mL Insulin Degludec	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05463744/flow